A novel SERS-lateral flow assay (LFA) tray for monitoring of miR-155-5p during pyroptosis in breast cancer cells

被引:1
|
作者
Lu, Xiaoxia [1 ,2 ]
Lu, Wenlong [3 ]
Hua, Dong [1 ,4 ]
机构
[1] Soochow Univ, Affiliated Hosp 2, Dept Oncol, Suzhou 214122, Peoples R China
[2] Yangzhou Univ, Dept Oncol, Affiliated Hosp, Yangzhou 225000, Peoples R China
[3] Taizhou Womens & Childrens Hosp, Dept Pharm & Equipment, Taizhou 225300, Jiangsu, Peoples R China
[4] Nanjing Med Univ, Wuxi Peoples Hosp, Wuxi 21411, Jiangsu, Peoples R China
关键词
ENHANCED RAMAN-SCATTERING; HOT-SPOTS; NANOPARTICLES; SILVER; NANORODS; SPECTROSCOPY; GROWTH; TAGS;
D O I
10.1039/d4ay00363b
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
In the study, a novel surface-enhanced Raman scattering (SERS)-lateral flow assay (LFA) tray for the real-time detection of pyroptosis-associated miR-155-5p in breast cancer cells was established and validated. The SERS probe modified with monoclonal antibodies and functionalized HP1@5-FAM was first synthesized. When miR-155-5p was present, HP1@5-FAM on the SERS probe specifically recognized target miRNAs and hybridized with them, resulting in HP2 on the T line only capturing some SERS probes that were not bound to miR-155-5p. The T line appeared as a light orange band or there was no color change, and the corresponding Raman detection result showed a weak or insignificant Raman signal. The SERS probe showed high selectivity, satisfactory stability, and excellent reproducibility, and the limit of detection (LOD) for miR-155-5p was 7.26 aM. Finally, the proposed SERS-LFA tray was applied to detect miR-155-5p in MBA-MD-468 cells that underwent varying degrees of pyroptosis, and the detection results of SERS were consistent with those of the conventional real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay. The study demonstrated that the SERS-LFA tray was a convenient and ultrasensitive method for miR-155-5p real-time detection, which could provide more detailed information for pyroptosis and be of potential value in guiding the treatment of breast cancer. Upon addition of cell lysates to the sample pad, SERS probes located on the conjugation pad would bind to target miRNAs, leading to no captured SERS probes and no discernible color change on the T line.
引用
收藏
页码:3878 / 3894
页数:17
相关论文
共 26 条
  • [1] miR-155-5p antagonizes the apoptotic effect of bufalin in triple-negative breast cancer cells
    Wang, Qian
    Li, Ce
    Zhu, Zhitu
    Teng, Yuee
    Che, Xiaofang
    Wang, Yan
    Ma, Yanju
    Wang, Yiding
    Zheng, Huachuan
    Liu, Yunpeng
    Qu, Xiujuan
    ANTI-CANCER DRUGS, 2016, 27 (01) : 9 - 16
  • [2] Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells
    Su, Nana
    Li, Lanlan
    Zhou, Erle
    Li, Hong
    Wu, Shuhua
    Cao, Zhang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [3] Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells
    Su, Nana
    Li, Lanlan
    Zhou, Erle
    Li, Hong
    Wu, Shuhua
    Cao, Zhang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [4] Resveratrol Downregulates miR-155-5p to Block the Malignant Behavior of Gastric Cancer Cells
    Su, Nana
    Li, Lanlan
    Zhou, Erle
    Li, Hong
    Wu, Shuhua
    Cao, Zhang
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [5] miR-155-5p Facilitates the Growth of Lobaplatin-Treated Gastric Cancer Cells
    Gao, Yuewen
    Wang, Yanqin
    Meng, Lingxin
    Wang, Kai
    Liu, Xiaoyong
    Chen, Lei
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2023, 37 (03): : 1325 - 1334
  • [6] Clinical association of miR-155-5p with breast cancer and its relevance for treatment with PARP inhibitors
    Pasculli, Barbara
    Barbano, Raffaela
    Fontana, Andrea
    Biagini, Tommaso
    Di Viesti, Maria Pia
    Rendina, Michelina
    Valori, Vanna Maria
    Morritti, Maria
    Bravaccini, Sara
    Ravaioli, Sara
    Maiello, Evaristo
    Graziano, Paolo
    Murgo, Roberto
    Copetti, Massimiliano
    Mazza, Tommaso
    Fazio, Vito Michele
    Esteller, Manel
    Parrella, Paola
    CANCER RESEARCH, 2020, 80 (16)
  • [7] Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis
    Xu, Wen
    Song, Changfeng
    Wang, Xiaotong
    Li, Yueqi
    Bai, Xue
    Liang, Xin
    Wu, Jingjing
    Liu, Jianwen
    AGING-US, 2021, 13 (01): : 228 - 240
  • [8] miR-155-5p expression is associated with response to neoadjuvant paclitaxel treatment of locally advanced breast cancer
    Straume, Anne Hege
    Birkeland, Einar
    Knappskog, Stian
    Lemning, Per Eystein
    CANCER RESEARCH, 2015, 75
  • [9] miR-155-5p increases the sensitivity of liver cancer cells to adriamycin by regulating ATG5-mediated autophagy
    Yu, Qiu
    Xu, Xiao-Ping
    Yin, Xin-Min
    Peng, Xiang-Qun
    NEOPLASMA, 2021, 68 (01) : 87 - 95
  • [10] NT21MP negatively regulates paclitaxel-resistant cells by targeting miR-155-3p and miR-155-5p via the CXCR4 pathway in breast cancer
    Wang, Yueyue
    Yan, Lei
    Zhang, Lingyu
    Xu, Henan
    Chen, Tiantian
    Li, Yu
    Wang, Haifeng
    Chen, Sulian
    Wang, Wenrui
    Chen, Changjie
    Yang, Qingling
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 53 (03) : 1043 - 1054